Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: J Urol. 2014 Aug 20;193(2):513–518. doi: 10.1016/j.juro.2014.08.081

Table 3.

Univariate Analysis for presence of teratoma in RPLND specimen (n=579)

Teratoma in RPLND specimen OR 95 % CI p value
 Clinical Stage
  I Ref
  IIA 0.5 0.2 to 0.7 0.02
  IIB/C 0.4 0.2 to 0.6 <0.001
  III 0.3 0.1 to 0.5 <0.001
 Any EC orchiectomy 1.4 0.95 to 2.2 0.08
 Any Yolk Sac 2.5 1.7 to 3.5 <0.001
 Any Teratoma 6.2 4.3 to 9.0 <0.001
 Year of Surgery (Before 1999 vs. After 1999) 0.8 0.5 to 1.1 0.1
 Pre-chemotherapy RP node size (continuous) 1.0 0.95 to 1.1 0.6
 Pre-surgery RP node size (continuous) 2.9 2.1 to 4.0 <0.001
 Chemotherapy (EP vs. BEP) 2.5 1.5 to 4.2 <0.001